Skip to main content
  • More from ADA
    • Diabetes
    • Diabetes Care
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Clinical Diabetes

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
  • Browse
    • Issue Archive
    • Saved Searches
    • COVID-19 Article Collection
    • Quality Improvement Sucess Stories
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
  • Advertising
  • Reprints/Reuse
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • Instructions for Authors
    • ADA Journal Policies
  • More from ADA
    • Diabetes
    • Diabetes Care
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Clinical Diabetes
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
  • Browse
    • Issue Archive
    • Saved Searches
    • COVID-19 Article Collection
    • Quality Improvement Sucess Stories
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
  • Advertising
  • Reprints/Reuse
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • Instructions for Authors
    • ADA Journal Policies
Feature Articles

Continuous Glucose Monitoring As a Behavior Modification Tool

  1. Nicole Ehrhardt⇑ and
  2. Enas Al Zaghal
  1. Division of Endocrinology, George Washington University, Washington, DC
  1. Corresponding author: Nicole Ehrhardt, nehrhardt{at}mfa.gwu.edu
Clinical Diabetes 2020 Apr; 38(2): 126-131. https://doi.org/10.2337/cd19-0037
PreviousNext
  • Article
  • Figures & Tables
  • Info & Metrics
  • PDF
Loading

Article Figures & Tables

Figures

  • Tables
  • FIGURE 1
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1

    CGM questionnaire. Demographic questions included in the survey are not shown.

Tables

  • Figures
  • TABLE 1

    Baseline Characteristics of Study Participants

    Participants (n = 40)
    Age, years36 (19–68)
    Weight, lb180 (111–253)
    BMI, kg/m227.8 (21.0–47.0)
    Sex
     Male19 (47.5)
     Female21 (52.5)
    Ethnicity
     African American2 (5)
     Caucasian33 (82.5)
     Asian2 (5)
     Multiple races reported3 (7.5)
    Reported A1C, %7.5 (5.5–9.0)
    CGM brand
     Medtronic16 (40)
     Dexcom22(55)
     FreeStyle Libre0 (0)
     Missing information2 (5)
    CGM use duration
     <3 months5 (12.5)
     3–6 months5 (12.5)
     6–12 months4 (10.0)
     1–2 years6 (15.0)
     2–3 years4 (10.0)
     >3 years16 (40.0)
    Insulin delivery
     MDI regimen9 (22.5)
     Insulin pump31 (77.5)
    • Data are mean (range) or n (%).

  • TABLE 2

    Key Survey Findings

    Question.Yes.No.Do Not Know.Did Before CGM UseMissing Information
    Noticed how food affects sugar?87.5 (35)7.5 (3)5.0 (2)——
    Excluded or limited sugared beverages?2.5 (1)13.0 (5)—82.5 (33)2.5 (1)
    Excluded or limited rice?22.5 (9)55.0 (22)—22.5 (9)—
    Excluded or limited cereals?15.0 (6)40.0 (16)—45.0 (18)—
    Read labels for fiber content?15.0 (6)30 (12)5.0 (2)50.0 (20)—
    Increased activity or exercised more?42.5 (17)22.5 (9)7.5 (3)27.5 (11)—
    Were more likely to go for a walk or perform physical activity after a meal in response to rising blood glucose levels on CGM system?47.5 (19)35 (14)5.0 (2)12.5 (5)—
    CGM contributed to a healthier lifestyle?90.0 (36)2.5 (1)2.5 (1)—5.0 (2)
    • Data are % (n).

PreviousNext
Back to top
Clinical Diabetes: 38 (2)

In this Issue

April 2020, 38(2)
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by Author
  • Masthead (PDF)
Sign up to receive current issue alerts
View Selected Citations (0)
Print
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Clinical Diabetes.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Continuous Glucose Monitoring As a Behavior Modification Tool
(Your Name) has forwarded a page to you from Clinical Diabetes
(Your Name) thought you would like to see this page from the Clinical Diabetes web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Continuous Glucose Monitoring As a Behavior Modification Tool
Nicole Ehrhardt, Enas Al Zaghal
Clinical Diabetes Apr 2020, 38 (2) 126-131; DOI: 10.2337/cd19-0037

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

Continuous Glucose Monitoring As a Behavior Modification Tool
Nicole Ehrhardt, Enas Al Zaghal
Clinical Diabetes Apr 2020, 38 (2) 126-131; DOI: 10.2337/cd19-0037
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Objective
    • Research Design and Methods
    • Results
    • Discussion
    • Conclusion
    • Article Information
    • Footnotes
    • References
  • Figures & Tables
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Improved Glycemic Control Following Transition to Tubeless Insulin Pump Therapy in Adults With Type 1 Diabetes
  • Practical Strategies to Help Reduce Added Sugars Consumption to Support Glycemic and Weight Management Goals
  • “Counting Carbs to Be in Charge”: A Comparison of an Internet-Based Education Module With In-Class Education in Adolescents With Type 1 Diabetes
Show more Feature Articles

Similar Articles

Navigate

  • Current Issue
  • Papers in Press
  • Abridged Standards of Care
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes
  • Diabetes Care
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Clinical Diabetes Print ISSN: 0891-8929, Online ISSN: 1945-4953.